QuiVad

Home / United States / Altamira Therapeutics Ltd. Shs (CYTOF)

Altamira Therapeutics Ltd. Shs (CYTOF)

Short position disclosed on September 15, 2026.

Follow

FINRA publishes, twice a month, the number of shares sold short in each company. Their share of the stock is computed here on the count the company reports to the SEC, and this market appears in no ranking shared with the others.

Evolution of the disclosed total

05K10K15K20K
Jul 30Aug 14Aug 29Sep 13
Number of shares sold short. Hover or tap the curve to see which funds make it up.

Open positions

The funds disclosing a short position that is still open.
FundTwelve monthsShares sold shortOver the yearSince
Aggregated total16,963 shares-287 sharesSeptember 15, 2026

Follow by RSS

Get the moves on Altamira Therapeutics Ltd. Shs (CYTOF) by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

5 disclosures on record for this share.
DateFundShares sold shortEnd of publication
September 15, 2026Aggregated total16,963 sharesstill open
August 31, 2026Aggregated total16,845 shares
August 14, 2026Aggregated total16,987 shares
July 31, 2026Aggregated total16,859 shares
July 15, 2026Aggregated total17,250 shares

Download 5 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the United States

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Altamira Therapeutics Ltd. Shs (CYTOF), source FINRA, data as at September 15, 2026, https://www.quivad.com/action/altamira-therapeutics-ltd-shs-cytof